Literature DB >> 10759781

Humoral autoreactivity directed against surfactant protein-A (SP-A) in rheumatoid arthritis synovial fluids.

P K Trinder1, T P Hickling, R B Sim, D Brackertz, M Loos, M J Maeurer.   

Abstract

SP-A is found principally in the lung, and has been associated with lamellar bodies also found in the synovial joint. Both SP-A and C1q contain collagen-like regions, and SP-A and C1q have some structural similarities, both having a globular head region and a collagen-like tail. Here we are able to show that (i) autoreactivity to SP-A, as expressed by IgG and IgM autoantibodies, is present in synovial fluid (SF) isolated from patients with rheumatoid arthritis (RA); (ii) in absorption experiments only a limited degree of cross-reactivity between autoantibodies reactive with C1q and SP-A is observed; (iii) there is no cross-reactivity between autoantibodies reactive with type II collagen (CII) and those reactive with SP-A or C1q; (iv) autoantibodies react with polymeric (dimers and larger) SP-A, but not with monomeric SP-A subunits, indicating that a degree of quaternary structure is required for antibody binding. Unlike CII, which not accessible in the normal joint, both SP-A and C1q are available within the SF in patients with RA and may therefore provide antigens driving an autoimmune response directed against collagen-like structures.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759781      PMCID: PMC1905629          DOI: 10.1046/j.1365-2249.2000.01185.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Mesothelium secretes lamellar bodies in a similar manner to type II pneumocyte secretion of surfactant.

Authors:  J W Dobbie; J K Lloyd
Journal:  Perit Dial Int       Date:  1989       Impact factor: 1.756

2.  Common epitopes in Clq and collagen type II.

Authors:  H P Heinz; K Rubin; A B Laurell; M Loos
Journal:  Mol Immunol       Date:  1989-02       Impact factor: 4.407

3.  Antibody to a cryptic, solid phase C1Q antigen in membranoproliferative nephritis.

Authors:  C F Strife; A E Leahy; C D West
Journal:  Kidney Int       Date:  1989-03       Impact factor: 10.612

4.  Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.

Authors:  M H Wener; S Uwatoko; M Mannik
Journal:  Arthritis Rheum       Date:  1989-05

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Purification and characterization of human, guinea pig and mouse C1q by fast protein liquid chromatography (FPLC).

Authors:  F Stemmer; M Loos
Journal:  J Immunol Methods       Date:  1984-11-16       Impact factor: 2.303

7.  IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis.

Authors:  C E Siegert; M R Daha; E A van der Voort; F C Breedveld
Journal:  Arthritis Rheum       Date:  1990-11

8.  Increased expression of C1q receptors on neutrophils from inflammatory joint fluids.

Authors:  A D Crockard; J M Thompson; R Malhotra; T A McNeill
Journal:  Immunol Lett       Date:  1993-05       Impact factor: 3.685

9.  Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.

Authors:  U Antes; H P Heinz; M Loos
Journal:  Arthritis Rheum       Date:  1988-04

10.  Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.

Authors:  J J Wisnieski; G B Naff
Journal:  Arthritis Rheum       Date:  1989-09
View more
  2 in total

1.  Increased expression of surfactant protein A and D in rheumatoid arthritic synovial fluid (RASF).

Authors:  Orhan Kankavi
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

2.  An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity.

Authors:  Annapurna Nayak; Eswari Dodagatta-Marri; Anthony George Tsolaki; Uday Kishore
Journal:  Front Immunol       Date:  2012-06-07       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.